Yahoo · Oct 28, 2026
Post-Q3 Earnings: Is SNDL Stock a Portfolio Must-Have?
SNDL's Q3 sales beat expectations, but margin pressure and persistent cannabis weakness cloud its recovery. Can buybacks and U.S. expansion turn the tide?
AC
NASDAQ · ACB
Aurora Cannabis Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$5.16
Up+$0.08 (+1.55%)
Updated Nov 4, 2026, 11:08 PM
SID Score
6.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 217.76M
- P/E ratio
- 7.31
- Dividend yield
- 0.00%
- 52-week range
- $2.56 – $6.36
- Volume
- 9.02M
- Avg. volume
- 1.65M
Price performance · ACB
ACB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
ACB closed at $5.16 after 21 trading sessions, up 12.42% for the selected period.
- Last close
- $5.16
- Period change
- +12.42%
- Period low
- $3.88
- Period high
- $5.16
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $4.71 | $5.20 | $4.71 | $5.16 | 9.02M |
| Nov 2, 2026 | $4.16 | $4.34 | $4.09 | $4.22 | 2.04M |
| Oct 30, 2026 | $4.03 | $4.09 | $3.98 | $4.06 | 807.14K |
| Oct 29, 2026 | $4.05 | $4.14 | $4.04 | $4.08 | 509.99K |
| Oct 28, 2026 | $4.09 | $4.10 | $3.985 | $4.08 | 555.46K |
| Oct 27, 2026 | $3.90 | $4.155 | $3.90 | $4.15 | 579.16K |
| Oct 26, 2026 | $3.85 | $3.95 | $3.84 | $3.90 | 494.67K |
| Oct 23, 2026 | $3.96 | $3.96 | $3.87 | $3.88 | 602.88K |
| Oct 22, 2026 | $3.93 | $4.06 | $3.90 | $3.97 | 683.4K |
| Oct 21, 2026 | $3.98 | $4.09 | $3.92 | $3.96 | 821.3K |
| Oct 20, 2026 | $3.90 | $4.06 | $3.90 | $3.97 | 654.31K |
| Oct 19, 2026 | $4.00 | $4.09 | $3.96 | $3.96 | 617.77K |
| Oct 16, 2026 | $4.11 | $4.12 | $3.98 | $3.99 | 995.32K |
| Oct 15, 2026 | $4.15 | $4.2251 | $4.08 | $4.10 | 891.67K |
| Oct 14, 2026 | $4.21 | $4.31 | $4.13 | $4.17 | 1.19M |
| Oct 13, 2026 | $4.25 | $4.34 | $4.24 | $4.29 | 650.2K |
| Oct 12, 2026 | $4.51 | $4.55 | $4.29 | $4.35 | 603.94K |
| Oct 9, 2026 | $4.41 | $4.575 | $4.40 | $4.49 | 1.35M |
| Oct 8, 2026 | $4.45 | $4.50 | $4.37 | $4.43 | 1.47M |
| Oct 7, 2026 | $4.59 | $4.67 | $4.44 | $4.46 | 1.38M |
| Oct 6, 2026 | $4.58 | $4.64 | $4.40 | $4.59 | 1.94M |
Latest ACB news
The latest Smart Investors Daily articles mentioning ACB.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ACB research
Overview
Company profile and research snapshot.
Company profile
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $5.92
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | ATB CAPITAL MARKETS | Outperform | — |
| Aug 18, 2026 | TD COWEN | Buy | — |
| Aug 5, 2026 | CANACCORD GENUITY | Buy | — |
| Aug 5, 2026 | ROTH CAPITAL PARTNERS | Neutral | — |
| Aug 5, 2026 | ZUANIC & ASSOCIATES | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 27, 2026
Curaleaf Responds to Alberta Securities Commission Decision
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today issued the following statement in response to the Alberta Securities Commission's ruling regarding Aurora Cannabis Inc.'s ("Aurora") at-the-market ("ATM") program.
Yahoo · Oct 26, 2026
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) to halt Aurora's at-the-market ("ATM") program was dismissed by the Alberta Securities Commission.
Benzinga · Oct 26, 2026
Alberta Securities Commission Dismisses Curaleaf Holdings's Application To Halt Aurora Cannabis' February At-The-Market Program
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
